Trial
NCT00278928
Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or Plastic
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
—
Condition
Hypertriglyceridemia
Intervention
Liposyn III 20% (lipid infusion)
Why stopped
Manufacturing change in one of the two lipid emulsion products being studied.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-14